Intuitive Surgical (NASDAQ:ISRG) Given New $575.00 Price Target at Jefferies Financial Group

Intuitive Surgical (NASDAQ:ISRG) had its price objective lifted by Jefferies Financial Group from $475.00 to $575.00 in a research report released on Monday.

Other analysts also recently issued reports about the company. Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday. Citigroup lifted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday. BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Down 1.8 %

Shares of ISRG stock opened at $573.48 on Monday. The stock’s fifty day simple moving average is $547.16 and its 200 day simple moving average is $505.21. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the stock. Silver Oak Securities Incorporated boosted its stake in Intuitive Surgical by 12.8% in the 4th quarter. Silver Oak Securities Incorporated now owns 1,784 shares of the medical equipment provider’s stock worth $940,000 after purchasing an additional 203 shares in the last quarter. Legacy CG LLC raised its holdings in shares of Intuitive Surgical by 28.1% in the fourth quarter. Legacy CG LLC now owns 8,479 shares of the medical equipment provider’s stock worth $4,426,000 after buying an additional 1,861 shares during the last quarter. YANKCOM Partnership acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $441,000. Bleakley Financial Group LLC grew its holdings in shares of Intuitive Surgical by 12.6% during the fourth quarter. Bleakley Financial Group LLC now owns 9,433 shares of the medical equipment provider’s stock valued at $4,923,000 after buying an additional 1,055 shares during the last quarter. Finally, Kercheville Advisors LLC increased its position in shares of Intuitive Surgical by 25.1% in the 4th quarter. Kercheville Advisors LLC now owns 1,070 shares of the medical equipment provider’s stock valued at $558,000 after acquiring an additional 215 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.